Skip to content
Head to head

Glaukos vs Abbott Laboratories

Side-by-side on the measures that matter, with a plain-English read. Full detail: GKOS · ABT

Updated 9 minutes ago

1-year performance, rebased to 100

GKOS +168.5%ABT -19.3%
Abbott Laboratories edges it on the scoreable measures. Abbott Laboratories pays the highest dividend yield; Abbott Laboratories earns the most per share.
GKOSABT
Snapshot
SectorMedical DevicesMedical Devices
Last price237.31103.00
Change today-0.33%-0.84%
1-year return+149.3%-15.4%
Market cap$14.05B$178.39B
52-week range93.96 – 255.1980.89 – 126.70
Valuation
P/E (TTM)-80.4438.29
P/E percentile, own 5-yr range1st99th
P/B19.583.50
Dividend yield0.00%2.41%
Profitability & growth
EPS (TTM)-3.283.72
Net profit (TTM)$-194.17M$6.44B
Revenue (TTM)$690.33M$48.23B
Provider revenue period date2026-09-292026-09-29
Revenue growth (YoY)+58.0%+14.5%
Gross margin64.8%56.9%
Operating margin-25.3%13.8%
Net margin-24.6%9.7%
Free cash flow (TTM)$19.41M$6.76B
Provider cash-flow period date2026-09-292026-09-29
Ownership & sentiment
Institutional ownership108.0%81.2%
Insider activity (12mo)17 buy / 33 sell36 buy / 12 sell
Short interest (% of float)7.6%1.1%
Analyst consensus91% buy / 9% hold (11)93% buy / 7% hold (15)
Analyst price target$238 (+0%)$122 (+18%)
StockVane view
StockVane Quant RatingC (99)D (22)
Company
Employees1,094115,000
Founded19981900

▲ marks the more favourable stock(s) on measures with a clear direction (lower P/E, higher yield, higher Quant Rating, better 1-year return). Analyst consensus counts each covering institution once, at its most recent rating. Not a recommendation. Quant Rating method: Data & Methodology.